Newsletter - July 25, 2019
CBD and Stem Cells Show How FDA‘s Enforcement Discretion is Misused by All
This week FDA issued a detailed Warning Letter to one of the country’s most prolific sellers of CBD products, Cureleaf. The Cureleaf Warning Letter lists numerous violations of the drug laws namely in the lofty and mostly dubious claims made by the company for its CBD products and false attempts to label their products as dietary supplements...Read More
Early Adopters of Smartphone-based Healthcare Show Interesting Trends
An editorial in the British Medical Journal provides one of the first clinical perspective on smartphone based basic healthcare from a large real world data. Patients in London were provided a smartphone app-based algorithm, called GP at Hand, where almost all initial contacts between patients and physicians...Read More
CBD and Stem Cells Show How FDA‘s Enforcement Discretion is Misused by All
This week FDA issued a detailed Warning Letter to one of the country’s most prolific sellers of CBD products, Cureleaf. The Cureleaf Warning Letter lists numerous violations of the drug laws namely in the lofty and mostly dubious claims made by the company for its CBD products and false attempts to label their products as dietary supplements...Read More
Early Adopters of Smartphone-based Healthcare Show Interesting Trends
An editorial in the British Medical Journal provides one of the first clinical perspective on smartphone based basic healthcare from a large real world data. Patients in London were provided a smartphone app-based algorithm, called GP at Hand, where almost all initial contacts between patients and physicians...Read More